148 related articles for article (PubMed ID: 37340322)
1. Risk profiles and a concise prediction model for lymph node metastasis in patients with lung adenocarcinoma.
Liang S; Huang YY; Liu X; Wu LL; Hu Y; Ma G
J Cardiothorac Surg; 2023 Jun; 18(1):195. PubMed ID: 37340322
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma.
Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y
Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323
[TBL] [Abstract][Full Text] [Related]
3. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of ≤3 cm diameter.
Lin W; Huang M; Zhang Z; Chai T; Chen S; Gao L; Lin J; Kang M
Medicine (Baltimore); 2020 Sep; 99(36):e21453. PubMed ID: 32898994
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.
Hung JJ; Yeh YC; Jeng WJ; Wu YC; Chou TY; Hsu WH
Eur J Cardiothorac Surg; 2016 Aug; 50(2):329-36. PubMed ID: 26819290
[TBL] [Abstract][Full Text] [Related]
7. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma.
Mimae T; Tsutani Y; Miyata Y; Yoshiya T; Ibuki Y; Kushitani K; Takeshima Y; Nakayama H; Okumura S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1820-6. PubMed ID: 24507979
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
10. Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm.
Wo Y; Li H; Chen Z; Peng Y; Zhang Y; Ye T; Jiang W; Sun Y
Clin Lung Cancer; 2023 Jul; 24(5):437-444. PubMed ID: 37029008
[TBL] [Abstract][Full Text] [Related]
11. Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma.
Aokage K; Suzuki K; Wakabayashi M; Mizutani T; Hattori A; Fukuda H; Watanabe SI
Eur J Cardiothorac Surg; 2021 Jul; 60(1):64-71. PubMed ID: 33514999
[TBL] [Abstract][Full Text] [Related]
12. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter.
Fang C; Xiang Y; Han W
BMC Surg; 2022 Apr; 22(1):153. PubMed ID: 35488235
[TBL] [Abstract][Full Text] [Related]
13. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.
Liu Y; Kim J; Balagurunathan Y; Hawkins S; Stringfield O; Schabath MB; Li Q; Qu F; Liu S; Garcia AL; Ye Z; Gillies RJ
Med Phys; 2018 Jun; 45(6):2518-2526. PubMed ID: 29624702
[TBL] [Abstract][Full Text] [Related]
14. [Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].
Ota S; Inaba H; Yoshida H
Kyobu Geka; 2001 Dec; 54(13):1073-8; discussion 1078-81. PubMed ID: 11761888
[TBL] [Abstract][Full Text] [Related]
15. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
Zhao F; Zhao Y; Zhang Y; Sun H; Ye Z; Zhou G
Acad Radiol; 2023 Dec; 30(12):2870-2879. PubMed ID: 37003873
[TBL] [Abstract][Full Text] [Related]
16. Lymph node metastasis and its risk factors in T1 lung adenocarcinoma.
Zhang W; Mu G; Huang J; Bian C; Wang H; Gu Y; Xia Y; Chen L; Yuan M; Wang J
Thorac Cancer; 2023 Oct; 14(30):2993-3000. PubMed ID: 37667435
[TBL] [Abstract][Full Text] [Related]
17. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
[No Abstract] [Full Text] [Related]
18. Lymph node metastasis in clinical stage IA peripheral lung cancer.
Wang L; Jiang W; Zhan C; Shi Y; Zhang Y; Lin Z; Yuan Y; Wang Q
Lung Cancer; 2015 Oct; 90(1):41-6. PubMed ID: 26212683
[TBL] [Abstract][Full Text] [Related]
19. The value on SUV-derived parameters assessed on
Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
Zheng Y; Ju S; Huang R; Zhao J
J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
